Tecan Group

Tecan Group

Providing laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics.

Launch date
Employees
Market cap
CAD4.5b
Enterprise valuation
CAD4.5b (Public information from Sep 2024)
Zurich Canton of Zürich (HQ)

Financials

Estimates*

Edit
Revenues, earnings & profits over time
CHF2020202120222023202420252026
Revenues731m947m1.1b1.1b1.0b1.1b1.2b
% growth15 %30 %21 %(6 %)(6 %)8 %8 %
EBITDA153m207m214m201m184m221m246m
% EBITDA margin21 %22 %19 %19 %18 %20 %21 %
Profit104m122m121m132m96.4m128m146m
% profit margin14 %13 %11 %12 %9 %12 %12 %
EV / revenue6.5x7.5x4.5x4.0x3.5x3.1x2.8x
EV / EBITDA30.8x34.0x24.1x21.2x19.1x15.5x13.6x
R&D budget62.0m71.9m77.9m69.7m---
R&D % of revenue8 %8 %7 %6 %---
  • Edit
DateInvestorsAmountRound
N/A

N/A

IPO
Total Funding-

Recent News about Tecan Group

Edit

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.

Investments by Tecan Group

Edit
Andrew Alliance
ACQUISITION by Waters Corporation Jan 2020
SPEware Corp
ACQUISITION by Tecan Group Aug 2016
IBL International
ACQUISITION by Tecan Group Jul 2014
Sias AG
ACQUISITION by Tecan Group Oct 2015